Hualan Biological Bacterin Inc. (301207.SZ) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · China · ISIN CNE1000058J9
Hualan Biological Bacterin Inc. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 1.13 bn CNY | 1.20 bn CNY |
| Gross profit | 841.03 m CNY | 935.56 m CNY |
| Operating income | 214.86 m CNY | 187.60 m CNY |
| EBIT | 220.76 m CNY | 190.34 m CNY |
| Net income | 205.52 m CNY | 182.92 m CNY |
| Diluted EPS – continuing operations | 0.34 CNY | 0.30 CNY |
Full history since 2017, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Hualan Biological Bacterin Inc.
Hualan Biological Vaccine Inc. engages in the research and development, production, and sale of vaccines and genetically engineered biological products in China. The company's main products include influenza virus split vaccine, quadrivalent influenza virus split vaccine, quadrivalent influenza virus split vaccine (pediatric formulation), H1N1 influenza A virus split vaccine, ACYW135 group meningococcal polysaccharide vaccine, recombinant hepatitis B vaccine (Hansenula polymorpha), group A and C meningococcal polysaccharide vaccine, freeze-dried human rabies vaccine (Vero cells), and adsorbed tetanus vaccine. It also offers products under development, such as freeze-dried Group A and Group C meningococcal conjugate vaccine, adsorbed cell-free tridiphtheria-tetanus combined vaccine, freeze-dried Haemophilus influenzae type b conjugate vaccine, and recombinant zoster vaccine (CHO cells), mRNA influenza vaccines, adsorbed tetanus vaccine, and novel adjuvanted influenza vaccines. In addition, it sells self-produced products. The company was founded in 2005 and is based in Xinxiang, China.
More stocks
- TRUPANION, INC. (TRUP)
- Kunshan Huguang Auto Harness Co Ltd (605333.SS)
- Nh Special Purpose Acquisition 14 Co. Ltd (319400.KQ)
- Jinan Acetate Chemical Co Ltd (4763.TW)
- UPBOUND GROUP, INC. (UPBD)
- Yangling Metron New Material Co Ltd (300861.SZ)
- Lyntris Inc. (LYNX)
- Riskified Ltd (RSKD)
- Adient plc (ADNT)
- Shift Up Corporation (462870.KS)
- Damora Therapeutics, Inc. (DMRA)
- China Modern Dairy Holdings Ltd (1117.HK)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.